Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

Randomised comparison of the polymer-free biolimus-coated BioFreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with PCI: the SORT OUT IX Trial

03 Jul 2020

While investigations testing differences in efficacy and safety between drug-eluting stents according to the characteristics of the coating – durable, bioresorbable, or polymer-free – have shown mixed results, several studies have highlighted the benefit of implanting a device with thinner strut.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
The SORT OUT IX trial

Physiology or intracoronary imaging; or both? or none? - part 1

27 Jun 2020 – From PCR e-Course 2020

Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

Physiology or intracoronary imaging; or both? or none?

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

Ultrathin-strut vs. thin-strut DES for primary PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.

Videos included on this page: the Hot Line presentation...

Ultrathin-strut vs. thin-strut DES for primary PCI

Innovative solutions to treat diabetic patients

Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...

Innovative solutions to treat diabetic patients

The year in intervention: essential publications from EuroIntervention and the European Heart Journal

27 Jun 2020 – From PCR e-Course 2020

Watch this video to find out what were the most essential, impactful and influential papers published in EuroIntervention and the European Heart Journal over the past year, and learn more about the academic versus social impact of citations.

The year in intervention: essential publications from EuroIntervention and the European Heart Journal

Hot line on PCI: high bleeding risk and DAPT - part 1

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.

Hot line on PCI: high bleeding risk and DAPT

To stent or not to stent? Discussion of complex PCI cases

26 Jun 2020 – From PCR e-Course 2020

Watch this roundtable discussion if you want to join a detailed discussion about the drug-eluting stent vs. drug-coated balloon approach, to discuss the importance of lesion preparation for optimal coronary intervention results and to share insights about state-of-the-art treatment options from leading expert.

To stent or not to stent? Discussion of complex PCI cases

Current evidence for the interventional treatment of INOCA patients

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.

Current evidence for the interventional treatment of INOCA patients

Benefits of ultrathin DES in complex bifurcations - case based expert discussion

Watch this session if you want to assess the role of ultrathin DES in bifurcation treatment, to experience innovation in practice and to learn techniques for optimising outcomes in complex bifurcations.

Speakers: Hsien-Li Kao, Johan Bennett, Mathias Christoph Brandt

This interview supported by Biotronik was filmed at PCR...

Benefits of ultrathin